Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Read more about Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Read more about To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer Read more about Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer Read more about Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure Read more about Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer Read more about VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia Read more about A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) Read more about Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) Read more about A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia Read more about Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia